Toxoplasma gondii genotype determines MyD88-dependent signaling in infected macrophages

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2584-2591

  Kim, Leesun ^a   Butcher, Barbara A ^a   Lee, Chiang W ^a   Uematsu, Satoshi ^b   Akira, Shizuo ^b   Denkers, Eric Y ^a  

^a Department of Obstetrics Gynecology   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENZYME ACTIVATOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEVELOPMENTAL STAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GENOTYPE; HOST CELL; HOST PARASITE INTERACTION; MACROPHAGE; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTOZOAL INFECTION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TACHYZOITE; TOXOPLASMA GONDII;

EID: 33746864093     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2584     Document Type: Article

References (59)

1. Joynson, D. H., and T. J. Wreghitt. 2001. Toxoplasmosis: a comprehensive clinical guide. Cambridge University Press, Cambridge, U.K.
2. Fayer, R., J. P. Dubey, and D. S. Lindsay. 2004. Zoonotic protozoa: from land to sea. Trends Parasitol. 20: 531-536.
3. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
4. Denkers, E. Y., and R. T. Gazzinelli. 1998. Regulation and function of T cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11: 569-588.
5. Sher, A., C. Collazzo, C. Scanga, D. Jankovic, G. Yap, and J. Aliberti. 2003. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii. Immunol. Res. 27: 5221-5528.
6. Luft, B., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15: 211-222.
7. Remington, J. S., R. McLeod, P. Thuliez, and G. Desmonts. 2001. Toxoplasmosis. In Injections Diseases of the Fetus and Newborn Infant. J. S. Remington and J. O. Klein, eds. W. B. Saunders Co., Philadelphia, pp. 205-346.
8. Sibley, L. D., and J. C. Boothroyd. 1992. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359: 82-85.
9. Howe, D. K., and L. D. Sibley. 1995. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human diseases. J. Infect. Dis. 172: 1561-1566.
10. Sibley, L. D., and D. K. Howe. 1996. Genetic basis of pathogenicity in toxoplasmosis. Curr. Top. Microbiol. Immunol. 216: 4-15.
11. Darde, M. L., B. Bouteille, and M. Pestre-Alexandre. 1992. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J. Parasitol. 78: 786-794.
12. Barragan, A., and L. D. Sibley. 2003. Migration of Toxoplasma gondii across biological barriers. Trends Microbiol. 11: 426-430.
13. Gavrilescu, L. C., and E. Y. Denkers. 2001. IFN-γ overproduction and high level apoptosis arc associated with high but not low virulence Toxoplasma gondii infection. J. Immunol. 167: 902-909.
14. Mordue, D. G., F. Monroy, M. La Regina, C. A. Dinarello, and L. D. Sibley. 2001. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J. Immunol. 167: 4574-4584.
15. Boothroyd, J. C. and M. E. Grigg. 2002. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr. Opin. Microbiol. 5: 438-442.
16. Fuentes, I., J. M. Rubio, C. Ramirez, and J. Alvar. 2001. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J. Clin. Microbiol. 39: 1566-1570.
17. Grigg, M. E., J. Ganatra, J. C. Boothroyd, and T. P. Margolis. 2001. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 184: 633-639.
18. Khan, A., C. Su, M. German, G. A. Storch, D. B. Clifford, and L. D. Sibley. 2005. Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J. Clin. Microbiol. 43: 5881-5887.
19. Denkers, E. Y. 2003. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol. Med. Microbiol. 39: 193-203.
20. Gazzinelli, R. T., C. Ropert, and M. A. Campos. 2004. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol. Rev. 201: 9-25.
21. Sieling, P. A., and R. L. Modlin. 2001. Activation of Toll-like receptors by microbial lipoproteins. Scand J. Infect. Dis. 33: 97-100.
22. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
23. Bliss, S. K., B. A. Butcher, and E. Y. Denkers. 2000. Rapid recruitment of neutrophils with prestored IL-12 during microbial infection. J. Immunol. 165: 4515-4521.
24. Gazzinelli, R. T., S. Hieny, T. Wynn, S. Wolf, and A. Sher. 1993. IL-12 is required for the T-cell independent induction of IFN-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90: 6115-6119.
25. Reis e Sousa, C., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J. Exp. Med. 186: 1819-1829.
26. Hitziger, N., I. Dellacasa, B. Albiger, and A. Barragan. 2005. Dissemination of Toxoplasnm gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assesses by in vivo bioluminscence imaging. Cell. Microbiol. 6: 837-848.
27. Scanga, C. A., J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, and A. Sher. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168: 5997-6001.
28. Akira, S., and T. Takeda. 2004. Toll-like receptor signaling. Nat. Rev. Immunol. 4: 499-511.
29. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
30. Yarovinsky, F., D. Zhang, J. F. Anderson, G. L. Bannenberg, C. N. Serhan, M. S. Hayden, S. Hieny, F. S. Sutterwala, R. A. Flavell, S. Ghosh, and A. Sher. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629.
31. Del Rio, L., B. A. Butcher, S. Bennouna, S. Hieny, A. Sher, and E. Y. Denkers. 2004. Toxoplasma gondii triggers MyD88-dependent and CCL2 (MCP-1) responses using distinct parasite molecules and host receptors. J. Immunol. 172: 6954-6960.
32. Mun, H.-S., F. Aosai, K. Norose, M. Chen, L.-X. Piao, O. Takeuchi, S. Akira, H. Ishikura, and A. Yano. 2003. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Parasitol. 15: 1081-1087.
33. Aliberti, J., J. G. Valenzuela, V. B. Carruthers, S. Hieny, J. Andersen, H. Charest, C. Reis e Sousa, A. Fairlamb, J. M. Ribeiro, and A. Sher. 2003. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4: 485-490.
34. Kim, L., L. Del Rio, B. A. Butcher, T. H. Mogensen, S. Paludan, R. A. Flavell, and E. Y. Denkers. 2005. p38 MAPK autophosphorylation drives macrophage IL-12 production during intracellular infection. J. Immunol. 174: 4178-4184.
35. Mason, N. J., J. Fiore, T. Kobayashi, K. S. Masek, Y. Choi, and C. A. Hunter. 2004. TRAF6-dependent mitogen-activated protein kinase activation differentially regulates production of interleukin-12 by macrophages in response to Toxoplasma gondii. Infect. Immun. 72: 5662-5667.
36. Robben, P. M., D. G. Mordue, S. M. Truscott, K. Takeda, S. Akira, and L. D. Sibley. 2004. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 172: 3686-3694.
37. Kim, L., B. A. Butcher, and E. Y. Denkers. 2004. Toxoplasma gondii interferes with lipopolysaccharide-indueed mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance. J. Immunol. 172: 3003-3010.
38. Mogensen, T. H., K. Melchjorsen, P. Hollsberg, and S. R. Paludan. 2003. Activation of NF-κB in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-β-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and IκB kinase. J. Immunol. 170: 6224-6233.
39. Brumlik, M. J., S. Wei, K. Finstad, J. Nesbit, L. E. Hyman, M. Lacey, M. E. Burow, and T. J. Curiel. 2004. Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii. Int. J. Parasitol. 34: 1245-1254.
40. + dendritic cells. Nat. Immunol. 1: 83-87.
41. Kim, L., and E. Y. Denkers. 2006. Toxoplasma gondii triggers Gi-dependent phosphatidylinositol 3-kinase signaling required for inhibition of host cell apoptosis. J. Cell Sci. 119: 2119-2126.
42. Lee, J., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746.
43. Lee, J. C., and P. R. Young. 1996. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukocyte Biol. 59: 152-157.
44. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor pathway. Science 301: 640-643.
45. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72.
46. Butcher, B. A., L. Kim, P. F. Johnson, and E. Y. Denkers. 2001. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NFκB. J. Immunol. 167: 2193-2201.
47. Denkers, E. Y., L. Kim, and B. A. Butcher. 2003. In the belly of the beast: subversion of macrophage proinflammatory signaling cascades during Toxoplasma gondii infection. Cell Microbiol. 5: 75-83.
48. Luder, C. G. K., M. Algner, C. Lang, N. Bleicher, and U. Gross. 2003. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Int. J. Parasitol. 33: 833-844.
49. Butcher, B. A., L. Kim, A. Panopoulos, S. S. Watowich, P. J. Murray, and E. Y. Denkers. 2005. Cutting Edge: IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages. J. Immunol. 174: 3148-3152.
50. + monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201: 1761-1769.
51. Biragyn, A., P. A. Ruffini, C. A. Leifer, E. Klyushnenkova, A. Shakhov, O. Chertov, A. K. Shirakawa, J. M. Farber, D. M. Segal, J. J. Oppenheim, and L. W. Kwak. 2002. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298: 1025-1029.
52. Ohashi, K., V. Burkart, S. Flohe, and H. Kolb. 2000. Cutting Edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164: 558-561.
53. Rifkin, I. R., E. A. Leadbetter, L. Busconi, G. Viglianti, and A. Marshak-Rothstein. 2005. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204: 27-42.
54. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, L. Showe, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157: 4045-4054.
55. Camargo, M. M., I. C. Almeida, M. E. S. Pereira, M. A. J. Ferguson. L. R. Travassos, and R. T. Gazzinelli. 1997. Glycosylphosphotidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158: 5890-5901.
56. Camargo, M. M., A. C. Andrade, I. C. Almeida, L. R. Travassos, and R. T. Gazzinelli. 1997. Glycoconjugates isolated from Trypanosoma cruzi but not Leishmania sp. parasite membranes trigger nitric oxide synthesis as well as microbicidal activity by IFN-γ-primed macrophages. J. Immunol. 159: 6131-6139.
57. Almeida, I. C., M. M. Camargo, D. O. Procopia, M. S. Silva, A. Mehlert, L. R. Travassos, R. T. Gazzinelli, and M. J. Ferguson. 2000. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19: 1476-1485.
58. Debierre-Grockiego, F., N. Azzouz, J. Schmidt, J.-F. Dubremetz, H. Geyer, R. Geyer, R. Weingardt, R. R. Schmidt, and R. T. Schwartz. 2003. Roles of glycosylphosphatidylinositols of Toxoplasma gondii: induction of TNF-α production in macrophages. J. Biol. Chem. 278: 32987-32993.
59. Su, C., D. Evans, R. H. Cole, J. C. Kissinger, J. W. Ajioka, and L. D. Sibley. 2003. Recent expansion of Toxoplasma through enhanced oral transmission. Science 299: 414-416.